【米国NIHで開催】光免疫療法研究会の事前参加登録方法とプログラムについて

Morning Session 1 : Current State of NIR-PIT

「History and Current Status of Near Infrared Photoimmunotherapy of Cancer」
▶Hisataka Kobayashi
National Institutes of Health USA/Kansai Medical University Japan

「Mechanistic Insights into NIR-PIT」
▶Mikako Ogawa
Hokkaido University Japan

Morning Session 2 : Emerging uses of NIR-PIT for Pancreas cancer

「Emerging Uses for NIR-PIT for Pancreatic and Colon Cancers」
▶Michael Bouvet
University of California San Diego USA

「ANTXR2-Targeted NIR-PIT Eradicates Pancreatic Cancer Stem Cells」
▶Keiichi Nakayama
Institute of Science Tokyo Japan

「Metabolotheranostics of pancreatic cancer by targeting choline, glutamine, and glucose transporters with photoimmunotherapy」
▶Zaver Bhujwalla
Johns Hopkins University USA

Morning Session 3 : New Clinical Applications of EGFR targeted NIR-PIT

「HICARi Study: Phase II Trial of EGFR‑Targeted Photoimmunotherapy for Recurrent and Persistent Vulvar, Vaginal, and Cervical Cancers Not Amenable to Further Radiotherapy」
▶Hiroshi Asano・ Hidemichi Watari
Hokkaido University Japan

「title:ＴＢＡ（Glioblastoma application ）」
▶G.M.(Gooitzen Michell)Van Dam
University of Groningen　NLD

Afternoon Session 1 : Clinical outcome of NIR-PIT for head and neck cancer patients in Japan and USA

「Real-world data on Near-infrared photoimmunotherapy for head and neck cancer in Japan.」
▶Takahiro Asakage
Institute of Science Tokyo Japan

「Real-World Outcomes and Biological Insights of Photoimmunotherapy for Recurrent Nasopharyngeal Carcinoma: Findings from the NPC-PIT Nationwide Study」
▶Takeshi Shinozaki
National Cancer Center Hospital East Japan

「title:ＴＢＡ（Head and neck cancer; experience in the USA）」
▶David M. Cognetti
Thomas Jefferson University USA

Afternoon Session 2 : Other Applications of NIR-PIT

「Beyond the Cutting Edge:Revolutionizing Cancer Surgery with Theranostics」
▶James P. Basilion
Case Western Reserve University USA

「COVALENT LIGANDS FOR ENZYME TARGETS: POTENTIAL APPLICATIONS TO NIR-PIT」
▶Matthew Bogyo
Stanford University USA

Afternoon Session 3 : Newly Available Resources

「New PIT agents」
▶Peter L. Choyke
National Cancer Institute USA

「Development of novel photosensitizers for photoimmunotherapy, IR702HKT」
▶Hideo Takakura
Kansai Medical University Japan

「PDPN-Targeted NIR-PIT: Preclinical Evaluation and Clinical Applications」
▶Aki Furusawa
National Cancer Institute USA

「Combination Photoimmunotherapy and Immunocytokine Therapy」
▶Thinzar Helmi Lwin
City of Hope National Medical Center

他にもポスターセッションを予定しています。
みなさま、是非参加登録をお願いいたします。